1104 related articles for article (PubMed ID: 24862741)
1. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
3. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
4. Results of salvage liver transplantation.
Guerrini GP; Gerunda GE; Montalti R; Ballarin R; Cautero N; De Ruvo N; Spaggiari M; Di Benedetto F
Liver Int; 2014 Jul; 34(6):e96-e104. PubMed ID: 24517642
[TBL] [Abstract][Full Text] [Related]
5. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
11. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
[TBL] [Abstract][Full Text] [Related]
12. Primary results of salvage liver transplantation in the patients with unresectable recurrent hepatocellular carcinoma after initial liver resection.
Liang BY; Huang ZY; Zhou SJ; Hou P; Wang SF; Jiang B; Chen XP
Hepatogastroenterology; 2014 Oct; 61(135):2014-20. PubMed ID: 25713904
[TBL] [Abstract][Full Text] [Related]
13. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure?
De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A
J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072
[TBL] [Abstract][Full Text] [Related]
15. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.
N'Kontchou G; Aout M; Laurent A; Nahon P; Ganne-Carrié N; Grando V; Baghad I; Roulot D; Trinchet JC; Sellier N; Cherqui D; Vicaut E; Beaugrand M; Seror O
J Hepatol; 2012 Jan; 56(1):160-6. PubMed ID: 21703186
[TBL] [Abstract][Full Text] [Related]
16. Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation.
Nagai S; Abouljoud MS; Kazimi M; Brown KA; Moonka D; Yoshida A
Transplantation; 2014 Mar; 97(6):694-701. PubMed ID: 24637868
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM
Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
[TBL] [Abstract][Full Text] [Related]
19. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]